Oxycodone: Difference between revisions
No edit summary |
|||
Line 12: | Line 12: | ||
===Opioid-Experienced Patients=== | ===Opioid-Experienced Patients=== | ||
*Individualize based on current opioid intake q4-6h PRN | *Individualize based on current opioid intake q4-6h PRN | ||
**Use caution in older patients | |||
**See [[Opioids#Oral_Opioid_Dosing_Chart|Opioid Dosing Chart]] for dose conversion information | |||
**Taper dose by 25-50% q2-4 days to discontinue if long-term use | **Taper dose by 25-50% q2-4 days to discontinue if long-term use | ||
==Pediatric Dosing== | ==Pediatric Dosing== |
Revision as of 03:10, 2 May 2019
General
- Type: opioid
- Dosage Forms: PO
- Common Trade Names: Roxicodone, Oxycontin
Adult Dosing
Opioid-Naive Patients
- Start: 5-15mg PO q4-6h PRN
- Use lowest effective dose and shortest effective duration (NOT a first-line treatment)
- Use caution in older patients
Opioid-Experienced Patients
- Individualize based on current opioid intake q4-6h PRN
- Use caution in older patients
- See Opioid Dosing Chart for dose conversion information
- Taper dose by 25-50% q2-4 days to discontinue if long-term use
Pediatric Dosing
General Pain
- 0.05-0.15mg/kg PO q4-6h PRN
- Max: 5mg/dose
Special Populations
- Pregnancy Rating: C
- Lactation Risk Categories: possibly unsafe
- Renal Dosing
- Adult: CrCl < 60: decrease starting dose
- Pediatric: CrCl 10-50: decrease starting dose 25%, CrCL < 10: decrease dose 50%
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Respiratory Depression
- Apnea
- syncope
- bradycardia
- Seizures
- anaphylaxis
Common
- Nausea
- Rash
- Headache
- Fatigue
- xerostomia
- constipation
- Tremor
- transaminitis
Pharmacology
- Half-life: 3.5-4 hour
- Metabolism: Liver
- Excretion: urine
- Mechanism of Action:binds to various opioid receptors